pone.0294729.g002.tif (599 kB)

SNHG17 is highly expressed in DLBCL patients’ tumor cells and in B-lymphoma cell lines.

figure

posted on 2023-11-21, 18:30 authored by Shengjuan Lu, Lin Zeng, Guojun Mo, Danqing Lei, Yuanhong Li, Guodi Ou, Hailian Wu, Jie Sun, Chao Rong, Sha He, Dani Zhong, Qing Ke, Qingmei Zhang, Xiaohong Tan, Hong Cen, Xiaoxun Xie, Chengcheng Liao

(A) Survival analyses of GSE10846 (n = 420) in DLBCL patients with high and low expression of SNHG17.(B, C) Kaplan–Meier survival analysis. (D, E) Uniform and multivariate expression analyses (all bars correspond to the 95% confidence intervals). (F) Nomogram was used to predict the OS of patients. (G) Expression of SNHG17 in DLBCL patients’ tumor and normal tissues.The sequencing data for normal cells and diffuse large B-cell lymphoma were obtained from UCSC XENA, which we have described in the methods section. (H) qPCR shows the expression of SNHG17 in lymphoma cell lines (Daudi, Ramos, DoHH2, Farage, and Raji) and peripheral blood mononuclear cells (PBMC).*P < 0.05, **P < 0.01, ***P < 0.001.